These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14185934)

  • 1. [VARIATIONS IN THE ENZYME ACTIVITY AND PHARMACOLOGIC EFFECTS IN RELATION TO AGE].
    TRABUCCHI E; CHIESARA E
    G Gerontol Suppl; 1964; 23():SUPPL 32:71-99. PubMed ID: 14185934
    [No Abstract]   [Full Text] [Related]  

  • 2. VARIATION IN THE ACTIVITY OF LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES IN RATS IN RELATION TO THE AGE.
    KATO R; VASSANELLI P; FRONTINO G; CHIESARA E
    Biochem Pharmacol; 1964 Jul; 13():1037-51. PubMed ID: 14201126
    [No Abstract]   [Full Text] [Related]  

  • 3. FURTHER STUDIES ON THE INHIBITION AND STIMULATION OF MICROSOMAL DRUG METABOLIZING ENZYMES OF RAT LIVER BY VARIOUS COMPOUNDS.
    KATO R; CHIESARA E; VASSANELLI P
    Biochem Pharmacol; 1964 Jan; 13():69-83. PubMed ID: 14106733
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of some microsomal drug-metabolizing enzymes by inhibitors of cholesterol biosynthesis.
    KATO R; VASSANELLI P; CHIESARA E
    Biochem Pharmacol; 1963 Apr; 12():349-51. PubMed ID: 13958397
    [No Abstract]   [Full Text] [Related]  

  • 5. METABOLIC FACTORS DETERMINING A HIGHER RESISTANCE TO STRYCHNINE IN GUINEA PIGS.
    KATO R; VASSANELLI P; FRONTINO G
    Arch Int Pharmacodyn Ther; 1963 Aug; 144():416-22. PubMed ID: 14060864
    [No Abstract]   [Full Text] [Related]  

  • 6. APPLICATION OF DRUG METABOLISM TO DRUG TOXICITY STUDIES.
    BURNS JJ; CUCINELL SA; KOSTER R; CONNEY AH
    Ann N Y Acad Sci; 1965 Mar; 123():273-86. PubMed ID: 14329210
    [No Abstract]   [Full Text] [Related]  

  • 7. [ELECTROPHYSIOLOGICAL RESEARCH ON THE CHANGES IN THE STRYCHNINE POINTS INDUCED BY TREATMENT WITH PSYCHOTROPIC AND ANTICONVULSIVE DRUGS].
    ARRIGO A; SAVOLDI F; TARTARA A
    Riv Neurol; 1964; 34():311-9. PubMed ID: 14208874
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of drug metabolism in the mouse by a hypocholesterolemic agent, AY-9944.
    Marton AV; Chappel CI
    Experientia; 1964 Sep; 20(9):517-8. PubMed ID: 5856346
    [No Abstract]   [Full Text] [Related]  

  • 9. THIO ANALOGS OF CARISOPRODOL (N-ISOPROPYL-2-METHYL-2-PROPYL-1,3-PROPANEDIOL DICARBAMATE).
    LEAFFER MA; SKINNER WA
    J Med Chem; 1965 Mar; 8():208-12. PubMed ID: 14332662
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of ionizing radiations on the biochemistry of mammalian tissues. II. The influence of various chemical compounds on the radiation-induced changes in enzyme activities in certain rat tissues.
    HIETBRINK BE; RYAN BA; RAYMUND AB
    Q Prog Rep United States Air Force Radiat Lab Univ Chic; 1962 Jan; 42():16-27. PubMed ID: 13907221
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors.
    Kumar M; Dillon GH
    Eur J Pharmacol; 2016 Mar; 775():149-58. PubMed ID: 26872987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE PLACE OF ACETYLSALICYLIC ACID IN PSYCHOPHARMACOLOGY. AN EXPERIMENTAL STUDY.
    FROMMEL E; FLEURY C; LEDEBUR IV; BEGUIN M; FAMILY S
    Arzneimittelforschung; 1963 Oct; 13():851-6. PubMed ID: 14196759
    [No Abstract]   [Full Text] [Related]  

  • 13. Carisoprodol pharmacokinetics and distribution in the nucleus accumbens correlates with behavioral effects in rats independent from its metabolism to meprobamate.
    Carbonaro TM; Nguyen V; Forster MJ; Gatch MB; Prokai L
    Neuropharmacology; 2020 Sep; 174():108152. PubMed ID: 32479814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EFFECTS OF STRYCHNINE SULPHATE ON MAZE LEARNING IN RATS.
    ROSS RB
    Nature; 1964 Jan; 201():109-10. PubMed ID: 14085557
    [No Abstract]   [Full Text] [Related]  

  • 15. A REVIEW OF PHARMACOLOGIC AGENTS USED IN A PHYSICAL MEDICINE AND REHABILITATION SETTING.
    FORSTER S; BENTON JG
    Arch Phys Med Rehabil; 1964 Jun; 45():277-82. PubMed ID: 14154804
    [No Abstract]   [Full Text] [Related]  

  • 16. PSYCHOPHARMACOLOGICAL EFFECTS OF REVERSIBLE CHOLINESTERASE INHIBITION INDUCED BY N-METHYL 3-ISOPROPYL PHENYL CARBAMATE (COMPOUND 10854).
    GOLDBERG ME; JOHNSON HE; KNAAK JB; SMYTH HF
    J Pharmacol Exp Ther; 1963 Aug; 141():244-52. PubMed ID: 14060479
    [No Abstract]   [Full Text] [Related]  

  • 17. STUDIES OF POTENTIATION OF HEXOBARBITONE INFUSED INTRAVENOUSLY.
    MCCANCE I
    Arch Int Pharmacodyn Ther; 1964 Mar; 148():270-86. PubMed ID: 14171755
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?
    Bramness JG; Skurtveit S; Fauske L; Grung M; Molven A; Mørland J; Steen VM
    Pharmacogenetics; 2003 Jul; 13(7):383-8. PubMed ID: 12835613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ENDOCRINE MODIFICATION OF DRUG RESPONSES IN THE RAT.
    BOUSQUET WF; RUPE BD; MIYA TS
    J Pharmacol Exp Ther; 1965 Mar; 147():376-9. PubMed ID: 14269613
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic modeling of carisoprodol and meprobamate disposition in adults.
    Lewandowski TA
    Hum Exp Toxicol; 2017 Aug; 36(8):846-853. PubMed ID: 27758843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.